1. Home
  2. CGEM vs CVGW Comparison

CGEM vs CVGW Comparison

Compare CGEM & CVGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • CVGW
  • Stock Information
  • Founded
  • CGEM 2016
  • CVGW 1924
  • Country
  • CGEM United States
  • CVGW United States
  • Employees
  • CGEM N/A
  • CVGW N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • CVGW Specialty Foods
  • Sector
  • CGEM Health Care
  • CVGW Consumer Discretionary
  • Exchange
  • CGEM Nasdaq
  • CVGW Nasdaq
  • Market Cap
  • CGEM 530.0M
  • CVGW 473.8M
  • IPO Year
  • CGEM 2021
  • CVGW N/A
  • Fundamental
  • Price
  • CGEM $8.18
  • CVGW $26.32
  • Analyst Decision
  • CGEM Strong Buy
  • CVGW Strong Buy
  • Analyst Count
  • CGEM 6
  • CVGW 1
  • Target Price
  • CGEM $28.17
  • CVGW $35.00
  • AVG Volume (30 Days)
  • CGEM 331.3K
  • CVGW 243.8K
  • Earning Date
  • CGEM 08-07-2025
  • CVGW 09-08-2025
  • Dividend Yield
  • CGEM N/A
  • CVGW 3.04%
  • EPS Growth
  • CGEM N/A
  • CVGW N/A
  • EPS
  • CGEM N/A
  • CVGW 0.58
  • Revenue
  • CGEM N/A
  • CVGW $694,486,000.00
  • Revenue This Year
  • CGEM N/A
  • CVGW $9.87
  • Revenue Next Year
  • CGEM N/A
  • CVGW $4.33
  • P/E Ratio
  • CGEM N/A
  • CVGW $33.29
  • Revenue Growth
  • CGEM N/A
  • CVGW 12.92
  • 52 Week Low
  • CGEM $6.85
  • CVGW $20.30
  • 52 Week High
  • CGEM $20.96
  • CVGW $30.02
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 54.88
  • CVGW 46.71
  • Support Level
  • CGEM $7.42
  • CVGW $26.23
  • Resistance Level
  • CGEM $8.70
  • CVGW $27.30
  • Average True Range (ATR)
  • CGEM 0.38
  • CVGW 0.66
  • MACD
  • CGEM 0.09
  • CVGW -0.05
  • Stochastic Oscillator
  • CGEM 63.12
  • CVGW 22.56

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About CVGW Calavo Growers Inc.

Calavo Growers Inc is in the avocado industry and an expanding provider of value-added fresh food. The group markets and distribute avocados, prepared avocado products, and other perishable foods to retail grocery, foodservice, club stores, mass merchandisers, food distributors and wholesalers across the world. The company distributes its products both domestically and internationally and reports its operations in two different business segments: Grown and Prepared. The Grown segment consists of fresh avocados, tomatoes, and papayas. The Prepared segment comprises all other products including fresh-cut fruits and vegetables, ready-to-eat sandwiches, wraps, salads and snacks, guacamole, and salsa sold at retail and food service as well as avocado pulp sold to food service.

Share on Social Networks: